Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer

Ciara Duffy, Anabel Sorolla, Edina Wang, +10

npj Precision Oncology

Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers

Edina Wang, Anabel Sorolla, Paula Cunningham, +12

Oncogene

Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides

Anabel Sorolla, Edina Wang, Tristan D. Clemons, +7

Nanomedicine Nanotechnology Biology and Medicine

Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers

Jessica A. Kretzmann, Cameron W. Evans, Colette Moses, +12

Chemical Science

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer

Emily Golden, Eleanor Woodward, Agustin Sgro, +28

Nature Communications

Sensitizing basal-like breast cancer to chemotherapy using nanoparticles conjugated with interference peptide

Anabel Sorolla, Diwei Ho, Edina Wang, +6

Nanoscale

Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer

Charlene Waryah, Joseph Cursons, Momeneh Foroutan, +18

Advanced Science